Sparteine Oxidation Polymorphism in Denmark
- 1 November 1985
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 57 (5) , 357-360
- https://doi.org/10.1111/j.1600-0773.1985.tb00058.x
Abstract
Sparteine oxidation was polymorphic among 301 healthy Danish volunteers. Hence 22 subjects or 7.3% were phenotyped as poor metabolizers (PM) whereas 279 subjects were classified as extensive metabolizers (EM). The metabolic ratio (MR) between sparteine and 2- and 5-dehydrosparteine (% of dose) in 12 hrs urine ranged from 0.11-12.6 in EM and from 30-394 in PM. Urinary excretion of 2- and 5-dehydrosparteine also discriminated between PM and EM. Age, sex, and smoking habits did not influence the MR. This study confirms that sparteine is a useful probe drug in pharmacogenetic investigations.Keywords
This publication has 15 references indexed in Scilit:
- Inter-ethnic difference in sparteine oxidation among Ghanaians and GermansEuropean Journal of Clinical Pharmacology, 1985
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- A radiometric assay for debrisoquine 4-hydroxylase in human liver microsomesCanadian Journal of Physiology and Pharmacology, 1984
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- Comparative pharmacogenetics of sparteine and debrisoquineClinical Pharmacology & Therapeutics, 1983
- HIGH PLASMA CONCENTRATIONS OF β-RECEPTOR BLOCKING DRUGS AND DEFICIENT DEBRISOQUINE HYDROXYLATIONThe Lancet, 1982
- In vitro metabolism of sparteine by human liver: competitive inhibition by debrisoquineCanadian Journal of Physiology and Pharmacology, 1982
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Influence of the defective metabolism of sparteine on its pharmacokineticsEuropean Journal of Clinical Pharmacology, 1979
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979